Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
CPC Subgroup
C12N 15/1138

Full Title

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00) > Recombinant DNA-technology > DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); > Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides;

Top Applicants

Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT

  1. HARVARD UNIVERSITY US 8,321
  2. CHINESE ACADEMY OF SCIENCES 7,486
  3. UNIVERSITY OF CALIFORNIA US 7,320
  4. REGENERON PHARMACEUTICALS US 5,003
  5. INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
  6. UNIVERSITY OF PENNSYLVANIA US 4,213
  7. CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
  8. JIANGNAN UNIVERSITY 3,961
  9. ROCHE CH 3,792
  10. ILLUMINA US 3,692